Lung Cancer

The test was also approved as a companion diagnostic test to determine which select patients with metastatic castration-resistant prostate cancer could benefit from Rubraca, as well as for three frontline TKIs in patients with non-small cell lung cancer.

The FDA has approved a generic form of the intravenous chemotherapy pemetrexed for use by itself in patients with locally advanced or metastatic non-squamous non-small cell lung cancer that has not progressed following four cycles of initial platinum-based chemotherapy.

Specific measures of a tumor’s texture and intensity as they appear on CT images can help determine how much treatment patients with early stage lung cancer need, a study found.

In this episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Dan Tran about his journey with stage 4 lung cancer and what advice he offers other survivors and patients with cancer.

If approved by the FDA, Imfinzi could be administered every four weeks at a fixed dose in patients with stage 3 NSCLC after they received chemoradiation, as well as in patients with previously treated bladder cancer.

The Food and Drug Administration granted a priority review to the new drug application for trilaciclib for patients with small cell lung cancer.

“Therapeutic trials are very, very important because thanks to them, our patients are living longer,” said Dr. Narjust Duma. “But (physicians) also need to stop and ask how our patients are living.”

From Johnson & Johnson discontinuing their talc-based baby powder in the U.S. and Canada after numerous lawsuits that cited the talc, a mineral similar to asbestos, caused cancer, to the ramifications of delayed cancer surgeries being felt by patients, here’s everything happening in the cancer space this week.

Understanding lung cancer.

New therapies approved following innovative research are increasing survival rates for patients with advanced lung cancer.

How a cancer diagnosis leaves one woman feeling humbled.

Disparities in lung cancer care must be closed to improve patient outcomes.

The keynote speaker at the CURE® Patient-Focused Sessions at the Annual New York Lung Cancers Symposium® heeded warning signs and urges others to do the same.

Researchers combine therapies in clinical trials to find the best match for patients with small cell lung cancer.

An aptly named app brings community to patients and caregivers around the world.

From the latest report on the “State of Lung Cancer” to NASA-style workouts for patients with cancer, here’s what is making headlines in the cancer space this week.

Researchers have discovered that a diet rich in fiber and yogurt may protect against lung cancer.

For Lung Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space.

From a palliative care bill clearing the House to a Washington Redskins player revealing a cancer diagnosis, here’s what is making headlines in the cancer space this week.

After a 10-year battle with cancer, the beloved actress, wife, mother and advocate passed away at 80.

Traveling helped me remove myself from the storyline of cancer and reconnect with the world around me.

Here’s a sneak peek at what’s inside our Summer 2019 issue.

The American Lung Association’s chief medical officer discusses e-cigarette use and answers common questions surrounding this increasing epidemic.

The earlier lung cancer is detected, the better chance a person has of surviving the disease. Knowing the risk factors and statistics will help you to understand how you can minimize your possibility of developing the disease.

Sometimes in life, we are fortunate enough to meet an individual who inspires us, motivating us to be our best. I was fortunate to meet Valerie “Val” Betancourt, M.S.N., RN, NP-C, OCN, over 20 years ago. Little did I know this was going to be the beginning of a wonderful friendship.

From landmark Senate legislation to the Pink Lemonade Stand Challenge, here’s what is making headlines in the cancer space this week.

GO2 Foundation will recognize Prof. Peters at the 20th International Lung Cancer Congress for her leadership in lung cancer research.

GO2 Foundation will recognize Prof. Peters at the 20th International Lung Cancer Congress for her leadership in lung cancer research.

Given with each dose of chemotherapy, trilaciclib temporarily puts bone marrow to sleep, helping to prevent fevers, infections and hospital stays in patients with small cell lung cancer.